Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2009 May;31(5):611-7.
doi: 10.1002/hed.20989.

Effect of induction chemotherapy on speech and swallowing function in patients with oral tongue cancer

Denise A Barringer  1 , Katherine A Hutcheson, Erich M Sturgis, Merrill S Kies, Jan S Lewin
Affiliations
Clinical Trial

Effect of induction chemotherapy on speech and swallowing function in patients with oral tongue cancer

Denise A Barringer et al. Head Neck. 2009 May.

Abstract

Background: Swallowing physiology, diet, and patient-reported outcomes were evaluated after induction chemotherapy for oral tongue cancer.

Methods: Fifteen of 23 patients enrolled in a phase II clinical trial of induction chemotherapy followed by surgical resection for oral tongue cancer underwent instrumental and perceptual analysis of speech and swallowing. Oropharyngeal swallow efficiency (OPSE) was calculated. Patient-reported outcomes were collected. We compared pre- and postchemotherapy results.

Results: OPSE scores were not significantly different (p > .05) after induction chemotherapy; however, patient-reported swallowing and diet levels were significantly higher (p < .001 and p = .015, respectively). Diet levels improved from soft-chewable to full diet in most patients. Speech intelligibility did not change (p = .328).

Conclusion: It appears that induction chemotherapy has a negligible effect on speech and swallowing physiology but may provide symptomatic improvement of pain and swallowing after treatment. Further investigations are needed to corroborate these findings.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Treatment schema
Abbreviations: mg, milligrams: AUC, area under curve: m2, meter squared: q, every: d, day: RT, radiation therapy: CBDCA, carboplatin
Figure 2
Figure 2
OPSE for each bolus consistency before and after induction chemotherapy.
Figure 3
Figure 3
MDADI responses and PSS-HN scores for patient-reported diet levels.
Figure 4
Figure 4
Speech intelligibility ratings at baseline and after induction chemotherapy.
See this image and copyright information in PMC

References

    1. Monnerat C, Faivre S, Temam S, Bourhis J, Raymond E. End points for new agents in induction chemotherapy for locally advanced head and neck cancers. Ann Oncol. 2002;13:995–1006. - PubMed
    1. Licitra L, Vermorken JB. Is there still a role for neoadjuvant chemotherapy in head and neck cancer? Ann Oncol. 2004;15:7–11. - PubMed
    1. Sturgis EM, Moore BA, Glisson BS, Kies MS, Shin DM, Byers RM. Neoadjuvant chemotherapy for squamous cell carcinoma of the oral tongue in young adults: a case series. Head Neck. 2005;27:748–756. - PubMed
    1. Logemann JA. Evaluation and treatment of swallowing disorders. 2nd ed. Pro-Ed; Austin, TX: 1998. pp. 168–180.
    1. Hutcheson KA, Barringer DA, Rosenthal DI, et al. Swallowing outcomes after radiotherapy for laryngeal carcinoma. Arch Otolaryngol Head Neck Surg. 2008;134(2):1–7. - PubMed

Publication types

MeSH terms

LinkOut - more resources